PolyBio Research Foundation is excited to be leading the #LongCovid Research Consortium: a scientific collaboration between top global research teams to rapidly & comprensively study LongCovid, with a focus on the topic of SARS-CoV-2 persistence in tissue:

3/ Watch the full video on the PolyBio-supported UCSF Long Covid research team here:

2/ PolyBio CEO Dr. Amy Proal, and collaborators Dr.s Putrino, Peluso & Iwasaki are making the most of these academic-industry partnerships to drive forward Long Covid therapeutics; via their participation in the SPEAR study group. Partnering with Invivyd, the group will guide

Which bulb produces more near-infrared (NIR) light? Here we have an IR-SENSE photo comparing different light bulbs being operated at the same power. All appear as "warm white" color to the eye but the difference in the amount of invisible NIR light present is

“To get rid of HIV, we need to go after the virus, we need to go after the inflammation, we need the immune system to work better,” says Dr. Steve Deeks. “Over the last 20 years we have built up all these collaborations with industry, funders, and other academic groups trying to

Don’t miss this opportunity to learn about the impact of pathogens like SARS-CoV-2 on our body systems! PolyBio’s Fall symposium is less than 2 weeks away, on November 14th. Sign up now to hear about innovative projects from around the globe! https://t.co/PaB4kZaYsL

3/ Watch the full video exploring how UCSF researchers, with the support of PolyBio, have been able to make enormous strides in Long Covid research:

2/ The PASC Tissue Program is the first in the world to comprehensively sample multiple tissues including gut, lymph node, cerebrospinal fluid, and bone marrow to determine if tissue-based viral persistence contributes to Long COVID and can be altered via interventions targeting

UCSF researcher Dr. Tim Henrich describes how the PolyBio-supported PASC tissue program is changing the game: “What we’ve really been finding is that SARS-CoV-2 is able to persist for a long period of time in various tissues across the body… the gut, the bone marrow, the brain,

From Crisis to Cure: PolyBio is supporting top HIV researchers to pivot into the study and treatment of Long COVID. Watch the full video to learn how this collaboration is being maximized & driving forward innovative research: https://t.co/Fc6rLyNsab

5/ MICROFLUIDIC CAPTURE TO IDENTIFY POTENTIAL VIRAL PARTICLES IN LONG COVID BLOOD Dr. Shannon Stott 2:10-2:20 PM ET To analyze Long COVID blood samples with a novel microfluidic technology that isolates rare, intact SARS-CoV-2 viral particles from complex biofluids. If viral

4/ VALIDATION OF A CYTOMEGALOVIRUS-BASED BIOMARKER FOR ALZHEIMER’S DISEASE Dr. Ben Readhead 1:10-1:20 PM ET A project to validate a blood-based biomarker capable of reflecting the presence of activated microglia neuroimmune cells and Cytomegalovirus infection of the gut and

3/ OPTIMIZING FLUORESCENCE MICROSCOPY AS A HIGH THROUGHPUT METHOD FOR DETECTING BIOFILM IN FIBRINALOID MICROCLOTS Luane Spamer 11:40-11:50 AM ET A study employing advanced fluorescence microscopy to determine if fibrinaliod microclots isolated from Long COVID and ME/CFS blood

2/ MENSA VIRUS “IMMUNE SNAPSHOT” TESTING TO IDENTIFY LONG COVID CLINICAL TRIAL RESPONDERS 3:40-3:50 PM EST Dr. Francis Eun Lee A project to add MENSA testing to measure virus-specific plasmablast “immune snapshots” to a clinical trial at the Mount Sinai CoRE clinic. The Long

Get a glimpse of the most innovative diagnostics research in the complex chronic illness space at PolyBio’s Fall 2025 symposium. Here are four presenters whose diagnostics research is supported by PolyBio for Long Covid, Alzheimer’s, and more. You won’t want to miss it!

18/ Michael Peluso, MD 5:10 – 5:20 pm ET (9:10- 9:20 pm UTC) Supporting the immune response in Long COVID: INTERRUPT-LC—testing the drug Anktiva Marc Elia 5:20 – 5:30 pm ET (9:20- 9:30 pm UTC) Broad-spectrum monoclonal antibodies in the treatment of Long COVID (SPEAR working

17/ Zian Tseng, MD 4:50 – 5:00 pm ET (8:50- 9:00 pm UTC) The COVID POST SCD (POstmortem Systematic invesTigation of Sudden Cardiac Death) Study David Putrino, PhD 5:00 – 5:10 pm ET (9:00- 9:10 pm UTC) Combination antivirals in the treatment of Long COVID

16/ Amy Proal, PhD 4:30 – 4:40 pm ET (8:30- 8:40 pm UTC) Infections as drivers of human aging: a review of key mechanisms Mario Murakami, PhD 4:40 – 4:50 pm ET (8:40- 8:50 pm UTC) Vagus nerve sensitivity as a common infection-associated chronic disease mechanism

15/Marta Mirabent, PhD 4:00 – 4:10 pm ET (8:00- 8:10 pm UTC) SARS-CoV-2 persistence & T cell activity in the female reproductive tract  Mark Painter, PhD 4:10 – 4:20 pm ET (8:10- 8:20 pm UTC) T cells as biosensors of viral persistence in Long COVID  Marcelo Freire, DDS, PhD

14/ Timothy Henrich, MD 3:30 – 3:40 pm ET (7:30- 7:40 pm UTC) Long COVID tissue biopsy program update Francis Eun Lee, PhD 3:40 – 3:50 pm ET (7:40- 7:50 pm UTC) Use of MENSA to identify SARS-CoV-2 persistence and viral reactivation in Long COVID 3:50-4:00 pm ET Q&A

13/ Michael VanElzakker, PhD 3:00 – 3:10 pm ET (7:00- 7:10 pm UTC) Long COVID & ME/CFS neuroinflammation and neutrophil function Beverly Peng, PhD 3:10 – 3:20 pm ET (7:10- 7:20 pm UTC) Mapping the landscape of endometriosis tissue William Eimer, PhD 3:20 – 3:30 pm ET (7:20-

12/ Steven Deeks, MD 2:30 – 2:40 pm ET (6:30- 6:40 pm UTC) Pivoting LIINC into the study of ME/CFS pathogenesis Michael Peluso, MD 2:40 – 2:50 pm ET (6:40- 6:50 pm UTC) VIPER: a Long COVID diagnostic test validation program 2:50 – 3:00 pm ET (6:50 – 7:00 pm UTC) Q&A